参考文献/References:
[1]张韶东,于德祥,王金明,等.山东省≥18 岁人群精神分裂症患病率、生命质量、应对方式及社会功能现状研究[J].精神医学杂志,2012,25(3):168-171.
[2]Kurtz MM,Mueser KT,Thime WR,et al.Social skills training and computer-assisted cognitive remediation in schizophrenia[J].Schizophr Res,2015,162(1-3):35-41.
[3]Mosolov SN,Potapov AV,Ushakov UV,et al.Design and validation of standardized clinical and functional remission criteria in schizophrenia[J].Neuropsychiatr Dis Treat,2014(10):167-181.
[4]张明圆.精神科评定量表手册[M].长沙:湖南科学技术出版社,1998:166-168.
[5]于青,翟金国,赵靖平,等.综合技能训练对精神分裂症康复效果2年随访研究[J].中国健康心理学杂志,2013,21(9):1340-1342.
[6]徐小洁,傅廷东,黎赛英.功能训练对住院精神分裂症患者社会功能及生活质量的影响[J].福建医药杂志,2016,38(3):150-152.
[7]Almerie M Q,Marhi M O A,Alsabbagh M,et al.Social skills programmes for schizophrenia[J].Cochrane Database Syst Rev,2015,6(2):1-15.
[8]郭建兵,马文有,于振剑,等.探讨康复训练改善精神分裂症患者社会功能的作用[C]//心身医学学术会议.2014.
[9]龙艳,王丹励.生活社会技能训练对住院精神分裂症患者生活能力的影响[J].广东医学,2014,35(18):2963-2965.
[10]瞿礼华,韩桂香,朱杰,等.跨理论模型的健康教育在首发脑卒中患者康复训练依从性中的 应用及效果评价[J].按摩与康复医学,2017,8(6):69-71.
相似文献/References:
[1]邹超杰,程宇琪.肠道微生物在精神分裂症中的研究进展[J].医学信息,2018,31(02):29.[doi:10.3969/j.issn.1006-1959.2018.02.011]
ZOU Chao-jie,CHENG Yu-qi.Progress in the Study of Intestinal Microorganism in Schizophrenia[J].Journal of Medical Information,2018,31(03):29.[doi:10.3969/j.issn.1006-1959.2018.02.011]
[2]沈雪梅.齐拉西酮与奥氮平治疗首发精神分裂症
疗效及糖脂代谢的影响观察[J].医学信息,2018,31(06):130.[doi:10.3969/j.issn.1006-1959.2018.06.044]
SHEN XUE-mei.The Effect of Ziprasidone and Olanzapine in the Treatment of First Episode Schizophrenia and the Effect of Glycolipid Metabolism[J].Journal of Medical Information,2018,31(03):130.[doi:10.3969/j.issn.1006-1959.2018.06.044]
[3]陈功琦,梁道博.利培酮联合舍曲林治疗精神分裂症阴性症状
疗效和安全性的Meta分析[J].医学信息,2018,31(10):65.[doi:10.3969/j.issn.1006-1959.2018.10.020]
CHEN Gong-qi,LIANG Dao-bo.Meta Analysis of Efficacy and Safety of Risperidone Combined with Sertraline in the Treatment of Schizophrenia with Negative Symptoms[J].Journal of Medical Information,2018,31(03):65.[doi:10.3969/j.issn.1006-1959.2018.10.020]
[4]孙来顺.氨磺必利与利培酮对精神分裂症患者内分泌及糖脂代谢的影响[J].医学信息,2022,35(10):137.[doi:10.3969/j.issn.1006-1959.2022.10.033]
SUN Lai-shun.Effects of Amisulpride and Risperidone on Endocrine And Glucose and Lipid Metabolism in Patients with Schizophrenia[J].Journal of Medical Information,2022,35(03):137.[doi:10.3969/j.issn.1006-1959.2022.10.033]
[5]孙占娟.精神分裂症患者的认知康复治疗进展[J].医学信息,2018,31(13):52.[doi:10.3969/j.issn.1006-1959.2018.13.015]
SUN Zhan-juan.Progress in Cognitive Rehabilitation Therapy of Schizophrenia Patients[J].Journal of Medical Information,2018,31(03):52.[doi:10.3969/j.issn.1006-1959.2018.13.015]
[6]吴金丽.阿立哌唑的临床应用[J].医学信息,2018,31(14):42.[doi:10.3969/j.issn.1006-1959.2018.14.014]
WU Jin-li.Clinical Application of Aripiprazole[J].Journal of Medical Information,2018,31(03):42.[doi:10.3969/j.issn.1006-1959.2018.14.014]
[7]宋典雄.激励理论指导下的护理干预对精神分裂症患者的影响[J].医学信息,2018,31(18):166.[doi:10.3969/j.issn.1006-1959.2018.18.054]
SONG Dian-xiong.The Effect of Nursing Intervention under the Guidance of Motivation Theory on Patients with Schizophrenia[J].Journal of Medical Information,2018,31(03):166.[doi:10.3969/j.issn.1006-1959.2018.18.054]
[8]凌 梅,刘静芳.精神分裂症患者研究伙伴的相关研究进展[J].医学信息,2018,31(19):48.[doi:10.3969/j.issn.1006-1959.2018.19.016]
LING Mei,LIU Jing-fang.Progress in Research on Research Partners in Patients with Schizophrenia[J].Journal of Medical Information,2018,31(03):48.[doi:10.3969/j.issn.1006-1959.2018.19.016]
[9]韩佳睿,张 苹,张 媛.迟发性运动障碍与DNA甲基化之间关系的研究进展[J].医学信息,2018,31(20):32.[doi:10.3969/j.issn.1006-1959.2018.20.010]
HAN Jia-rui,ZHANG Ping,ZHANG Yuan.Advances in Research on the Relationship between Tardive Dyskinesia and DNA Methylation[J].Journal of Medical Information,2018,31(03):32.[doi:10.3969/j.issn.1006-1959.2018.20.010]
[10]陈宽玉,孔 骞,黄玉桃.首发缓解期精神分裂症患者日常生活模式的调查[J].医学信息,2019,32(04):182.[doi:10.3969/j.issn.1006-1959.2019.04.061]
CHEN Kuan-yu,KONG Qian,HUANG Yu-tao.Investigation on the Daily Life Pattern of Patients with Schizophrenia in the First Remission Period[J].Journal of Medical Information,2019,32(03):182.[doi:10.3969/j.issn.1006-1959.2019.04.061]